Dyslipidaemia

Dyslipidaemia refers to an imbalance in blood lipid levels, elevated triglycerides, low HDL cholesterol, raised LDL, or a combination of these. It is one of the leading modifiable risk factors for heart attack and stroke, and it is common across South and Southeast Asia, where diets high in refined carbohydrates and saturated fat, combined with low rates of physical activity, push lipid profiles in the wrong direction.

Medicine used to treat Dyslipidaemia

Lopid

Gemfibrozil

300mg

Indicated to support the reduction of triglycerides, developed to manage dyslipidaemia effectively.

From $1.92 / tablet View

What shifts the balance

Genetics account for some cases, familial dyslipidaemia runs in families and often needs early attention. More often the causes are lifestyle: a diet heavy in fried foods, white rice, and processed snacks; physical inactivity; excess weight around the abdomen; heavy alcohol intake; and poorly controlled type 2 diabetes or hypothyroidism. Secondary dyslipidaemia driven by these underlying conditions often improves considerably once the root cause is addressed.

How it is managed

Lifestyle change is the first step: reducing saturated fat, increasing fibre, exercising regularly, and limiting alcohol. When lipid levels remain out of range despite these changes, medicines are added. Fibrates such as gemfibrozil are particularly effective at lowering high triglycerides and raising HDL. Broader cholesterol management often requires a combination approach tailored to which lipid fraction is most out of range. Blood tests every few months track whether treatment is working.